Ventricular hypertrophy and cardiovascular mortality in hemodialysis patients with low educational level.
نویسندگان
چکیده
BACKGROUND Left ventricular hypertrophy is a strong predictor of mortality in chronic kidney patients. A previous study of our group has shown that chronic kidney patients with low educational level has more severe ventricular hypertrophy. OBJECTIVE To extend a previous study and to assess whether left ventricular hypertrophy can explain the association between schooling and cardiovascular mortality in hemodialysis patients. METHODS This study assessed 113 patients from January 2005 to March 2008 and followed them up until October 2010. Survival curves were built to compare all-cause and cardiovascular mortality of patients with up to three years of schooling (median schooling) and those with schooling of four years and over. Cox multiple models were built and adjusted to confounding variables. RESULTS Association between educational level and ventricular hypertrophy was observed. Statistical difference in all-cause and cardiovascular mortality between the different educational levels was observed at 5.5 years of follow-up. In the Cox model, ventricular hypertrophy and C-reactive protein associated with all-cause and cardiovascular mortality. The etiology of kidney failure associated with all-cause mortality, and creatinine associated with cardiovascular mortality. The association between educational level and mortality lost statistical significance in the adjusted model. CONCLUSION The results of this study confirm those of a previous study. In addition, they show that the higher cardiovascular mortality observed in patients with low educational level can be explained by risk factors of biochemical and cardiac morphological origin.
منابع مشابه
The relationship between Aldosterone level and various LV conditions in patients with End-stage renal disease
Background: Aldosterone has been assumed to be implicated in left ventricular hypertrophy (LVH). Preventing the progression of LVH in the early period of end-stage renal disease (ESRD) can increase patient survival. In this study, therefore, we analyzed the relationship between aldosterone level and LVH in ESRD patients who underwent hemodialysis at Fatemeh Zahra Hospital and Imam Khomeini Hosp...
متن کاملElectrocardiographic left ventricular hypertrophy is not associated with increased in-hospital adverse events in patients experiencing first non-ST segment elevation myocardial infarction: A single center study
Background: There is conflicting data about prognostic implication of electrocardiographic (ECG) left ventricular hypertrophy (LVH) in patients with first non- ST-segment elevation myocardial infarction (NSTEMI). We aimed to examine the association of left ventricular hypertrophy (LVH) on admission electrocardiogram with adverse outcomes in patients with NSTEMI. Methods: In the present study, ...
متن کاملReduction of left ventricular ejection fraction after a 12-month follow-up in hemodialysis patients
*Corresponding author: Arsalan Khaledifar, Email: [email protected] Introduction Cardiovascular disease is responsible for about 60% of mortality rate in hemodialysis patients that is 30 times more prevalent than in general population (1-2). Some predisposing factors to sudden death in these patients include left ventricular hypertrophy (LVH), electrolyte shifts in hemodialysis sessio...
متن کاملCharacterization of Cardiovascular Health for Chronic Dialysis Patients Using Continuous Non-Invasive Cardiac Output Monitoring
There were 485,000 end stage renal disease patients in the U.S. as of 2005 with 785,000 projected by 2020. Mortality while on chronic hemodialysis is very high reaching 65% at 5 years after starting hemodialysis [1]. The prevalence of cardiovascular disease and left ventricular hypertrophy in these patients is 40% and 75%, respectively [2]. Cardiovascular disease is the most common cause of dea...
متن کاملDoes frequent hemodialysis regimen results in regression of left ventricular mass compared to conventional hemodialysis?
Several advances in dialysis therapies have been made. Still, the mortality in end-stage renal disease (ESRD) remains high at rates exceeding 15%. Cardiovascular disease from heart failure or sudden death remains an important cause for mortality in these groups. The most common cardiac anomaly in ESRD is cardiac hypertrophy and this has been observed in 75% of patients at the time of starting d...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Arquivos brasileiros de cardiologia
دوره 98 1 شماره
صفحات -
تاریخ انتشار 2012